As a significant investor in the UK, Eli Lilly lays down the importance of international relationships in life sciences.
Trade and investment ties between the US and UK are deep and enduring, standing at the core of the UK-US special relationship. They provide a foundation on which to drive future investments. But the current lack of clarity around Brexit puts it at risk.
According to the 2018 CBI US Sterling Assets Report, supported by Eli Lilly and Company (Lilly), UK companies remain the single largest investor in the US, investing $569bn in the US as of the end of 2015. US companies also make up the single largest investors in the UK, accounting for 24.5 per cent of the UK’s inward investment and supporting 1,349,000 direct jobs. This reciprocal relationship has become an essential part of the UK economy and has helped to drive growth in many of our key sectors, including life sciences.
At Lilly, we have a long history of investing in the UK, having opened the doors to our first UK site in 1934.
Exclusive My CBI member-only content 
